Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

18 participants · First posted Aug 23, 2022

Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes

30 participants · First posted Aug 23, 2023

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

40 participants · First posted May 28, 2024

CPL-200-075

Sodium Lactate and Glucose

Rx

Dapagliflozin(Edistride, Farxiga, Forxiga, Qtern, Qternmet, Xigduo, Dapagliflozin Viatris, Ebymect)

C₂₁H₂₅ClO₆ · Rx

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

Study Shows SGLT2 Inhibitors Improve Renal Function in Non-Diabetic CKD Patients

SGLT2 Inhibitors Show Promise in Managing Chronic Kidney Disease in Real-World Settings

SGLT2 Inhibitors Reduce Gout Medication Burden in Patients with Type 2 Diabetes